WILMINGTON - Salesianum led the field at the Delcastle Invitational wrestling tournament, claiming the team title with 298 ...
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...
In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...
Novo Nordisk (NVO) stock slipped after ate-stage trial data for a higher-dose version of its popular obesity therapy, ...
As someone who never used to struggle with their weight while younger, I found getting heavier as I aged frustrating. I’m ...
Many providers are familiar with the latest weight-loss injections, but not all individuals are candidates for these prescription injections, says Dr. Millard. Ozempic is an FDA-approved ...
Although weight loss isn't everyone's primary goal, it often accompanies improved eating habits and regular exercise. However, staying on track can be tough, and numerous factors can hinder progress.